Novo Net Income Applicable To Common Shares from 2010 to 2026
| NOVA Stock | EUR 32.15 0.45 1.38% |
Net Income Applicable To Common Shares | First Reported 2010-12-31 | Previous Quarter 63.9 B | Current Value 47 B | Quarterly Volatility 8.5 B |
Check Novo Nordisk financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novo Nordisk's main balance sheet or income statement drivers, such as Tax Provision of 16.5 B, Interest Income of 1.3 B or Interest Expense of 4.4 B, as well as many indicators such as . Novo financial statements analysis is a perfect complement when working with Novo Nordisk Valuation or Volatility modules.
Novo | Net Income Applicable To Common Shares |
The Net Income Applicable To Common Shares trend for Novo Nordisk AS offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Novo Nordisk is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Novo Nordisk's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Novo Nordisk AS over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Novo Nordisk's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novo Nordisk's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Novo Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 44,029,526,471 | |
| Geometric Mean | 43,330,976,469 | |
| Coefficient Of Variation | 19.39 | |
| Mean Deviation | 7,176,798,962 | |
| Median | 38,628,000,000 | |
| Standard Deviation | 8,537,885,533 | |
| Sample Variance | 72895489.4T | |
| Range | 25.9B | |
| R-Value | 0.81 | |
| Mean Square Error | 27097697.5T | |
| R-Squared | 0.65 | |
| Significance | 0.00009 | |
| Slope | 1,364,700,613 | |
| Total Sum of Squares | 1166327829.9T |
Novo Net Income Applicable To Common Shares History
About Novo Nordisk Financial Statements
Novo Nordisk stakeholders use historical fundamental indicators, such as Novo Nordisk's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Novo Nordisk investors may analyze each financial statement separately, they are all interrelated. For example, changes in Novo Nordisk's assets and liabilities are reflected in the revenues and expenses on Novo Nordisk's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Novo Nordisk AS. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 63.9 B | 47 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Novo Nordisk Correlation against competitors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.